|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Total revenue | |||||
| Costs and Expenses: | |||||
| Cost of revenues | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Separation expenses | |||||
| Litigation settlements and related expenses | |||||
| Depreciation and amortization | |||||
| Transaction related expenses | |||||
| Strategic review and transaction related expenses | |||||
| Total costs and expenses | |||||
| Operating Loss | |||||
| Other Income (Expense): | |||||
| Change in fair value of warrant liability | |||||
| Interest and investment income | |||||
| Gain on sale of investment | |||||
| Interest expense | |||||
| Gain on bargain purchase | |||||
| Gain on debt redemption | |||||
| Total other income, net | |||||
| Net loss before income taxes | |||||
| Income tax expense | |||||
| Net (loss) income from continuing operations, net of tax | |||||
| Net loss from discontinued operations | |||||
| Gain on sale of discontinued operations | |||||
| Income tax effect on discontinued operations | |||||
| Net income from discontinued operations, net of tax | |||||
| Net loss | |||||
| Continuing operations (in dollars per share) | |||||
| Discontinued operations (in dollars per share) | |||||
| Basic net loss per common share (in Dollars per share) | |||||
| Diluted net loss per common share (in Dollars per share) | |||||
| Weighted-average shares outstanding - basic (in Shares) | |||||
| Weighted-average shares outstanding - diluted (in Shares) | |||||
Loading...